Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment
Paul, James M., Toosi, Behzad, Vizeacoumar, Frederick S., Bhanumathy, Kalpana Kalyanasundaram, Li, Yue, Gerger, Courtney, Zawily, Amr El, Freywald, Tanya, Anderson, Deborah H., Mousseau, Darrell, KantVolume:
7
Journal:
Oncotarget
DOI:
10.18632/oncotarget.10569
Date:
August, 2016
File:
PDF, 11.69 MB
2016